Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evaluation of hypertrophic cardiomyopathy: new horizons for CMR?

Literature DB >> 20390060

Evaluation of hypertrophic cardiomyopathy: new horizons for CMR?

E E van der Wall¹, H M Siebelink, J J Bax.

Abstract

Entities: Disease

Year: 2010 PMID： 20390060 PMCID： PMC2848352 DOI： 10.1007/bf03091748

Source DB: PubMed Journal: Neth Heart J ISSN： 1568-5888 Impact factor: 2.380

× No keyword cloud information.

28 in total

1. The athlete's heart. A meta-analysis of cardiac structure and function.

Authors: B M Pluim; A H Zwinderman; A van der Laarse; E E van der Wall
Journal: Circulation Date: 2000-01-25 Impact factor: 29.690

2. Cardiac first-pass and myocardial perfusion in normal subjects assessed by sub-second Gd-DTPA enhanced MR imaging.

Authors: F P van Rugge; J J Boreel; E E van der Wall; P R van Dijkman; A van der Laarse; J Doornbos; A de Roos; J A den Boer; A V Bruschke; A E van Voorthuisen
Journal: J Comput Assist Tomogr Date: 1991 Nov-Dec Impact factor: 1.826

Review 3. New diagnostic options in hypertrophic cardiomyopathy.

Authors: J L Posma; E E van der Wall; P K Blanksma; E van der Wall; K I Lie
Journal: Am Heart J Date: 1996-11 Impact factor: 4.749

4. 'No-reflow' after acute myocardial infarction: direct visualisation of microvascular obstruction by gadolinium-enhanced CMR.

Authors: R Nijveldt; A M Beek; A Hirsch; M B M Hofman; V A W M Umans; P R Algra; A C van Rossum
Journal: Neth Heart J Date: 2008-05 Impact factor: 2.380

5. Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers.

Authors: J T Vehmeijer; I Christiaans; I M van Langen; E Birnie; G J Bonsel; E M A Smets; A A M Wilde
Journal: Neth Heart J Date: 2009-12 Impact factor: 2.380

6. Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity?

Authors: I A W van Rijsingen; J F Hermans-van Ast; Y H J M Arens; S M Schalla; C E M de Die-Smulders; A van den Wijngaard; Y M Pinto
Journal: Neth Heart J Date: 2009-12 Impact factor: 2.380

7. The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy.

Authors: M A G M Olimulder; J van Es; M A Galjee
Journal: Neth Heart J Date: 2009-12 Impact factor: 2.380

8. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors: James C C Moon; Emma Reed; Mary N Sheppard; Andrew G Elkington; Siew Yen Ho; Margaret Burke; Mario Petrou; Dudley J Pennell
Journal: J Am Coll Cardiol Date: 2004-06-16 Impact factor: 24.094

9. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors: Perry Elliott; Bert Andersson; Eloisa Arbustini; Zofia Bilinska; Franco Cecchi; Philippe Charron; Olivier Dubourg; Uwe Kühl; Bernhard Maisch; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Claudio Rapezzi; Petar Seferovic; Luigi Tavazzi; Andre Keren
Journal: Eur Heart J Date: 2007-10-04 Impact factor: 29.983

10. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Authors: Theano Papavassiliu; Tjeerd Germans; Stephan Flüchter; Christina Doesch; Anton Suriyakamar; Dariusch Haghi; Tim Süselbeck; Christian Wolpert; Dietmar Dinter; Stefan O Schoenberg; Albert C van Rossum; Martin Borggrefe
Journal: J Cardiovasc Magn Reson Date: 2009-09-09 Impact factor: 5.364

6 in total

Evaluation of hypertrophic cardiomyopathy: new horizons for CMR?

1. The athlete's heart. A meta-analysis of cardiac structure and function.

2. Cardiac first-pass and myocardial perfusion in normal subjects assessed by sub-second Gd-DTPA enhanced MR imaging.

Review 3. New diagnostic options in hypertrophic cardiomyopathy.

4. 'No-reflow' after acute myocardial infarction: direct visualisation of microvascular obstruction by gadolinium-enhanced CMR.

5. Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers.

6. Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity?

7. The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy.

8. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

9. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

10. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.

1. The NHJ 2012 in retrospect: which articles are cited most?

2. Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability.

3. Cardiac magnetic resonance imaging analysis in STEMI: quantitative or still visual?

4. Speckle tracking: distinction of physiologic from pathologic LVH?

5. CMR-determined scar volume: predictive for ventricular tachycardias?

6. Aortic stiffness in type-1 diabetes mellitus; beware of hypertension.